001     841765
005     20210129232102.0
024 7 _ |a 10.1007/s00062-017-0651-3
|2 doi
024 7 _ |a 0939-7116
|2 ISSN
024 7 _ |a 1615-6706
|2 ISSN
024 7 _ |a 1869-1439
|2 ISSN
024 7 _ |a 1869-1447
|2 ISSN
024 7 _ |a pmid:29260256
|2 pmid
024 7 _ |a WOS:000459774900018
|2 WOS
037 _ _ |a FZJ-2018-00069
082 _ _ |a 610
100 1 _ |a Maus, Volker
|0 0000-0001-5097-2631
|b 0
|e Corresponding author
245 _ _ |a Mechanical Thrombectomy in Basilar Artery Occlusion
260 _ _ |a München
|c 2019
|b Urban & Vogel
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1551800387_21036
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundMechanical thrombectomy (MT) of basilar artery occlusions (BAO) is a subject of debate. We investigated the clinical outcome of MT in BAO and predictors of a favorable outcome.Material and MethodsA total of 104 MTs of BAO (carried out between 2010 and 2016) were analyzed. Favorable outcome as a modified Rankin scale (mRS) ≤ 2 at 90 days was the primary endpoint. The influence of the following variables on outcome was investigated: number of detectable posterior communicating arteries (PcoAs), patency of basilar tip, completeness of BAO and posterior circulation Alberta Stroke Program early computed tomography score (PC-ASPECTS). Secondary endpoints were technical periprocedural parameters including symptomatic intracranial hemorrhage (sICH).ResultsThe favorable clinical outcome at 90 days was 25% and mortality was 43%. The rate of successful reperfusion, i.e. modified thrombolysis in cerebral infarction (mTICI) ≥ 2b was 82%. Presence of bilateral PcoAs (area under the curve, AUC: 0.81, odds ratio, OR: 4.2, 2.2–8.2; p < 0.0001), lower National Institute of Health Stroke Scale (NIHSS) on admission (AUC: 0.74, OR: 2.6, 1.3–5.2; p < 0.01), PC-ASPECTS ≥ 9 (AUC: 0.72, OR: 4.2, 1.5–11.9; p < 0.01), incomplete BAO (AUC: 0.66, OR: 2.6, 1.4–4.8; p < 0.001), and basilar tip patency (AUC: 0.66, OR: 2.5, 1.3–4.8; p < 0.01) were associated with a favorable outcome. Stepwise logistic regression analysis revealed that the strongest predictors of favorable outcome at 90 days were bilateral PcoAs, low NIHSS on admission, and incomplete BAO (AUC: 0.923, OR: 7.2, 3–17.3; p < 0.0001).ConclusionThe use of MT for BAO is safe with high rates of successful reperfusion. Aside from baseline NIHSS and incomplete vessel occlusion, both known predictors of favorable outcome in anterior circulation events, we found that collateral flow based on the presence or absence of PcoAs had a decisive prognostic impact.
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kalkan, Alev
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Kabbasch, Christoph
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Abdullayev, Nuran
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Stetefeld, Henning
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Barnikol, Utako Birgit
|0 P:(DE-Juel1)131615
|b 5
700 1 _ |a Liebig, Thomas
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Dohmen, Christian
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fink, Gereon Rudolf
|0 P:(DE-Juel1)131720
|b 8
700 1 _ |a Borggrefe, Jan
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Mpotsaris, Anastasios
|0 P:(DE-HGF)0
|b 10
773 _ _ |a 10.1007/s00062-017-0651-3
|0 PERI:(DE-600)2232347-8
|n 1
|p 153–160
|t Clinical neuroradiology
|v 29
|y 2019
|x 1869-1447
856 4 _ |u https://juser.fz-juelich.de/record/841765/files/Maus2019_Article_MechanicalThrombectomyInBasila.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/841765/files/Maus2019_Article_MechanicalThrombectomyInBasila.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:841765
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN NEURORADIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21